Forward P/S Multiple: Strata Critical Medical (SRTA)
Business stability for Strata Critical Medical Inc (SRTA) is bolstered by rising demand for emergency medical transportation and aeromedical mobility. The forward P/S metric visualizes this trend, with the indicator currently standing at 1.80. Efficiency is driven by robotic assembly without manual labor, while its status as a permanent supplier of surgical instruments and implants ensures deep integration into the operational processes of leading clinics.
Summary analytical data breakdowns for Strata Medical (SRTA)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Strata Critical Medical Inc|SRTA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Strata Critical Medical Inc|SRTA - Company Aggregate Debts|Debt to Book Capitalization Ratio Strata Medical|SRTA - Company Long-Term Debt|Company Current Liabilities Strata Critical Medical|Quick Ratio blade.com
- financial results and valuation multiples details:
SRTA - Company Net Income|Expected Profit Strata Critical Medical Inc|SRTA - Market Cap to Net Income Ratio|Projected Price to Earnings Strata Critical Medical Corp|SRTA - PEG Multiple|EV/EBITDA Multiple Strata Medical|SRTA - Operating income before deduction of amortization|Earnings per share for the last twelve months Strata Critical Medical|SRTA - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months blade.com|SRTA - Net earnings per share growth this year|Earnings growth forecast for next year Strata Critical Medical Inc
- sales and revenue indicators:
Fundamental company analysis:SRTA (Strata Critical Medical)
Strata Critical Medical Inc (SRTA) maintains the status of a perpetual vendor by integrating consumables into surgical cycles, which allows market expectations for future revenue to be assessed via the projected P/S trend. This indicator correlates current market capitalization with forecasted sales to determine the business revaluation momentum; any extremes here signal a risk of overbought conditions or an undervaluation of the ecosystem's fundamental stability.
Who Strata Critical Medical Inc competes with
Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio treace.com TMCI|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Inc)|Price-to-Projected Revenue Ratio ClearPoint Neuro Inc.|Forward Price-to-Revenue Multiple Stereotaxis Corporation (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|vivani.com (VANI) - Price-to-Projected Revenue Ratio|XTNT - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple NMTC|MODD (Modular Med) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Myomo, Inc (MYO)|COCH (Envoy Medical Inc) - Forward Price to Sales|Forward P/S Multiple VVOS (Vivos Therapeutics)|Forward P/S Multiple envveno.com NVNO|SINT: Forward Price-to-Revenue Multiple|Tenon Medical Inc. - Price to Expected Revenue Ratio|LFWD: Forward P/S Multiple|Autonomix Medical (AMIX) - Forward P/S Multiple|Forward Price-to-Revenue Multiple IVF|BBLG: Forward Price to Sales|Forward P/S Multiple AXNX|Forward Price-to-Revenue Multiple BIOLASE Inc. BIOL|Price-to-Projected Revenue Ratio Dynatronics DYNT|Forward Price to Sales FNA|INVO Bio - Forward P/S Multiple
